Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jette Primdahl

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
EULAR Rheumatology Open|June 29, 2026
Healthcare providers' awareness and knowledge of recommendations on cardiovascular risk management in people with rheumatic and musculoskeletal diseases: a survey studyDina Husum, Julie Katrine Karstensen, Massimo Radin, et al.
The Journal of Cardiovascular Nursing|May 8, 2020
Illness Perception After Heart Valve Surgery: Differences Among Men and WomenMalene Haugaard Hansen, Jette Primdahl, Lars Riber, et al.
Annals of the Rheumatic Diseases|March 5, 2015
EULAR recommendations for patient education for people with inflammatory arthritisHeidi A Zangi, Mwidimi Ndosi, Jo Adams, et al.
Annals of the Rheumatic Diseases|February 11, 2025
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases - a systematic literature review informing the 2024 update of an international expert consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases|February 11, 2025
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
RMD Open|June 12, 2024
Evaluating the participation of junior members and patient and healthcare professionals representatives in EULAR task forces: results from an international surveyPierre-Antoine Juge, Tue Wenzel Kragstrup, Luis Fernando Perez-Garcia, et al.
BMJ Open|June 7, 2019
Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled studyOliver Hendricks, Tonny Elmose Andersen, Afshin Ashouri Christiansen, et al.
Annals of the Rheumatic Diseases|August 11, 2019
2019 EULAR recommendations for the generic core competences of health professionals in rheumatologyLisa Edelaar, Elena Nikiphorou, George E Fragoulis, et al.
Annals of the Rheumatic Diseases|April 8, 2026
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritisFaidra Laskou, Victoria Konzett, Josef S Smolen, et al.
Annals of the Rheumatic Diseases|April 17, 2026
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritisVictoria Konzett, Faidra Laskou, Josef S Smolen, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
EULAR Rheumatology Open|June 29, 2026
Healthcare providers' awareness and knowledge of recommendations on cardiovascular risk management in people with rheumatic and musculoskeletal diseases: a survey studyDina Husum, Julie Katrine Karstensen, Massimo Radin, et al.
The Journal of Cardiovascular Nursing|May 8, 2020
Illness Perception After Heart Valve Surgery: Differences Among Men and WomenMalene Haugaard Hansen, Jette Primdahl, Lars Riber, et al.
Annals of the Rheumatic Diseases|March 5, 2015
EULAR recommendations for patient education for people with inflammatory arthritisHeidi A Zangi, Mwidimi Ndosi, Jo Adams, et al.
Annals of the Rheumatic Diseases|February 11, 2025
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases - a systematic literature review informing the 2024 update of an international expert consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases|February 11, 2025
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
RMD Open|June 12, 2024
Evaluating the participation of junior members and patient and healthcare professionals representatives in EULAR task forces: results from an international surveyPierre-Antoine Juge, Tue Wenzel Kragstrup, Luis Fernando Perez-Garcia, et al.
BMJ Open|June 7, 2019
Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled studyOliver Hendricks, Tonny Elmose Andersen, Afshin Ashouri Christiansen, et al.
Annals of the Rheumatic Diseases|August 11, 2019
2019 EULAR recommendations for the generic core competences of health professionals in rheumatologyLisa Edelaar, Elena Nikiphorou, George E Fragoulis, et al.
Annals of the Rheumatic Diseases|April 8, 2026
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritisFaidra Laskou, Victoria Konzett, Josef S Smolen, et al.
Annals of the Rheumatic Diseases|April 17, 2026
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritisVictoria Konzett, Faidra Laskou, Josef S Smolen, et al.
Pageof 10